Andrew R. Marks, MD - Publications

Affiliations: 
Physiology Columbia University College of Physicians and Surgeons, New York, NY, United States 
Area:
Ion channels, Ryanodine receptor biology, rapamycin resistance
Website:
http://www.markslab.columbia.edu

179/253 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Todd JJ, Lawal TA, Chrismer IC, Kokkinis A, Grunseich C, Jain MS, Waite MR, Biancavilla V, Pocock S, Brooks K, Mendoza CJ, Norato G, Cheung K, Riekhof W, Varma P, ... ... Marks AR, et al. Rycal S48168 (ARM210) for -related myopathies: a phase one, open-label, dose-escalation trial. Eclinicalmedicine. 68: 102433. PMID 38318125 DOI: 10.1016/j.eclinm.2024.102433  0.307
2024 Souidi M, Resta J, Dridi H, Sleiman Y, Reiken S, Formoso K, Colombani S, Amédro P, Meyer P, Charrabi A, Vincenti M, Liu Y, Soni RK, Lezoualc'h F, Stéphane Blot DVM, ... ... Marks AR, et al. Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy. Journal of Cachexia, Sarcopenia and Muscle. PMID 38221511 DOI: 10.1002/jcsm.13411  0.388
2023 Dridi H, Santulli G, Bahlouli L, Miotto MC, Weninger G, Marks AR. Mitochondrial Calcium Overload Plays a Causal Role in Oxidative Stress in the Failing Heart. Biomolecules. 13. PMID 37759809 DOI: 10.3390/biom13091409  0.304
2023 Dridi H, Liu Y, Reiken S, Liu X, Argyrousi EK, Yuan Q, Miotto MC, Sittenfeld L, Meddar A, Soni RK, Arancio O, Lacampagne A, Marks AR. Heart failure-induced cognitive dysfunction is mediated by intracellular Ca leak through ryanodine receptor type 2. Nature Neuroscience. PMID 37429912 DOI: 10.1038/s41593-023-01377-6  0.337
2023 Martuscello RT, Chen ML, Reiken S, Sittenfeld LR, Ruff DS, Ni CL, Lin CC, Pan MK, Louis ED, Marks AR, Kuo SH, Faust PL. Defective cerebellar ryanodine receptor type 1 and endoplasmic reticulum calcium 'leak' in tremor pathophysiology. Acta Neuropathologica. PMID 37335342 DOI: 10.1007/s00401-023-02602-z  0.35
2023 Marks AR. Targeting ryanodine receptors to treat human diseases. The Journal of Clinical Investigation. 133. PMID 36647824 DOI: 10.1172/JCI162891  0.403
2022 Miotto MC, Weninger G, Dridi H, Yuan Q, Liu Y, Wronska A, Melville Z, Sittenfeld L, Reiken S, Marks AR. Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Science Advances. 8: eabo1272. PMID 35857850 DOI: 10.1126/sciadv.abo1272  0.342
2022 Melville Z, Dridi H, Yuan Q, Reiken S, Wronska A, Liu Y, Clarke OB, Marks AR. A drug and ATP binding site in type 1 ryanodine receptor. Structure (London, England : 1993). PMID 35580609 DOI: 10.1016/j.str.2022.04.010  0.385
2022 Dridi H, Forrester F, Umanskaya A, Xie W, Reiken S, Lacampagne A, Marks A. Role of oxidation of excitation-contraction coupling machinery in age-dependent loss of muscle function in . Elife. 11. PMID 35506650 DOI: 10.7554/eLife.75529  0.331
2022 Dridi H, Santulli G, Gambardella J, Jankauskas SS, Yuan Q, Yang J, Reiken S, Wang X, Wronska A, Liu X, Lacampagne A, Marks AR. IP3 receptor orchestrates maladaptive vascular responses in heart failure. The Journal of Clinical Investigation. 132. PMID 35166236 DOI: 10.1172/JCI152859  0.307
2021 Yuan Q, Dridi H, Clarke OB, Reiken S, Melville Z, Wronska A, Kushnir A, Zalk R, Sittenfeld L, Marks AR. RyR1-related myopathy mutations in ATP and calcium binding sites impair channel regulation. Acta Neuropathologica Communications. 9: 186. PMID 34809703 DOI: 10.1186/s40478-021-01287-3  0.357
2021 Melville Z, Kim K, Clarke OB, Marks AR. High-resolution structure of the membrane-embedded skeletal muscle ryanodine receptor. Structure (London, England : 1993). PMID 34469755 DOI: 10.1016/j.str.2021.08.001  0.346
2021 Reiken S, Dridi H, Sittenfeld L, Liu X, Marks AR. Alzheimer's-like remodeling of neuronal ryanodine receptor in COVID-19. Biorxiv : the Preprint Server For Biology. PMID 33619477 DOI: 10.1101/2021.02.18.431811  0.35
2021 Dridi H, Wu W, Reiken SR, Ofer RM, Liu Y, Yuan Q, Sittenfeld L, Kushner J, Muchir A, Worman HJ, Marks AR. Ryanodine receptor remodeling in cardiomyopathy and muscular dystrophy caused by lamin A/C gene mutation. Human Molecular Genetics. PMID 33388782 DOI: 10.1093/hmg/ddaa278  0.407
2020 Dridi H, Kushnir A, Zalk R, Yuan Q, Melville Z, Marks AR. Reply to 'Mechanisms of ryanodine receptor 2 dysfunction in heart failure'. Nature Reviews. Cardiology. PMID 32901149 DOI: 10.1038/S41569-020-00444-W  0.369
2020 Dridi H, Liu X, Yuan Q, Reiken S, Mohamad Y, Sittenfeld LR, Apostolou P, Buron J, Sicard P, Matecki S, Thireau J, Menuet C, Lacampagne A, Marks AR. Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease. Jci Insight. PMID 32897880 DOI: 10.1172/Jci.Insight.140614  0.46
2020 Dridi H, Kushnir A, Zalk R, Yuan Q, Melville Z, Marks AR. Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target. Nature Reviews. Cardiology. PMID 32555383 DOI: 10.1038/S41569-020-0394-8  0.502
2020 Kushnir A, Todd JJ, Witherspoon JW, Yuan Q, Reiken S, Lin H, Munce RH, Wajsberg B, Melville Z, Clarke OB, Wedderburn-Pugh K, Wronska A, Razaqyar MS, Chrismer IC, Shelton MO, ... ... Marks AR, et al. Intracellular calcium leak as a therapeutic target for RYR1-related myopathies. Acta Neuropathologica. PMID 32236737 DOI: 10.1007/S00401-020-02150-W  0.42
2019 Dridi H, Yehya M, Barsotti R, Reiken S, Angebault C, Jung B, Jaber S, Marks AR, Lacampagne A, Matecki S. Mitochondrial oxidative stress induces leaky ryanodine receptor during mechanical ventilation. Free Radical Biology & Medicine. PMID 31756525 DOI: 10.1016/J.Freeradbiomed.2019.11.019  0.372
2019 Joseph LC, Avula UMR, Wan EY, Reyes MV, Lakkadi KR, Subramanyam P, Nakanishi K, Homma S, Muchir A, Pajvani UB, Thorp EB, Reiken SR, Marks AR, Colecraft HM, Morrow JP. Dietary Saturated Fat Promotes Arrhythmia by Activating NOX2 (NADPH Oxidase 2). Circulation. Arrhythmia and Electrophysiology. 12: e007573. PMID 31665913 DOI: 10.1161/Circep.119.007573  0.316
2018 Acimovic I, Refaat MM, Moreau A, Salykin A, Reiken S, Sleiman Y, Souidi M, Přibyl J, Kajava AV, Richard S, Lu JT, Chevalier P, Skládal P, Dvořak P, Rotrekl V, ... Marks AR, et al. Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes. Journal of Clinical Medicine. 7. PMID 30413023 DOI: 10.3390/Jcm7110423  0.365
2018 Kushnir A, Wajsberg B, Marks AR. Ryanodine receptor dysfunction in human disorders. Biochimica Et Biophysica Acta. 1865: 1687-1697. PMID 30040966 DOI: 10.1016/J.Bbamcr.2018.07.011  0.5
2018 Kushnir A, Santulli G, Reiken SR, Coromilas E, Godfrey SJ, Brunjes DL, Colombo PC, Yuzefpolskaya M, Sokol SI, Kitsis RN, Marks AR. Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure. Circulation. PMID 29593014 DOI: 10.1161/Circulationaha.117.032703  0.47
2018 Santulli G, Lewis D, des Georges A, Marks AR, Frank J. Ryanodine Receptor Structure and Function in Health and Disease. Sub-Cellular Biochemistry. 87: 329-352. PMID 29464565 DOI: 10.1007/978-981-10-7757-9_11  0.465
2018 Hartel AJW, Ong P, Schroeder I, Giese MH, Shekar S, Clarke OB, Zalk R, Marks AR, Hendrickson WA, Shepard KL. Single-channel recordings of RyR1 at microsecond resolution in CMOS-suspended membranes. Proceedings of the National Academy of Sciences of the United States of America. PMID 29432144 DOI: 10.1073/Pnas.1712313115  0.394
2017 Regan JN, Mikesell C, Reiken S, Xu H, Marks AR, Mohammad KS, Guise TA, Waning DL. Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model. Frontiers in Endocrinology. 8: 358. PMID 29312148 DOI: 10.3389/Fendo.2017.00358  0.356
2017 Santulli G, Lewis DR, Marks AR. Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor. Journal of Muscle Research and Cell Motility. PMID 28653141 DOI: 10.1007/S10974-017-9470-Z  0.468
2017 Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O, Bauer C, Duprat F, Briggs CA, Chakroborty S, Stutzmann GE, ... ... Marks AR, et al. Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits. Acta Neuropathologica. PMID 28631094 DOI: 10.1007/S00401-017-1733-7  0.406
2017 Su M, Gao F, Yuan Q, Mao Y, Li DL, Guo Y, Yang C, Wang XH, Bruni R, Kloss B, Zhao H, Zeng Y, Zhang FB, Marks AR, Hendrickson WA, et al. Structural basis for conductance through TRIC cation channels. Nature Communications. 8: 15103. PMID 28524849 DOI: 10.1038/Ncomms15103  0.366
2017 Zalk R, Marks AR. Ca(2+) Release Channels Join the 'Resolution Revolution'. Trends in Biochemical Sciences. 42: 543-555. PMID 28499500 DOI: 10.1016/J.Tibs.2017.04.005  0.497
2017 Bussiere R, Lacampagne A, Reiken S, Liu X, Scheuerman V, Zalk R, Martin C, Checler F, Marks AR, Chami M. Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor. The Journal of Biological Chemistry. PMID 28476886 DOI: 10.1074/Jbc.M116.743070  0.398
2017 Santulli G, Nakashima R, Yuan Q, Marks AR. Intracellular calcium release channels: an update. The Journal of Physiology. PMID 28303572 DOI: 10.1113/Jp272781  0.49
2017 Hartel AJ, Ong P, Schroeder I, Clarke O, Shekar S, Giese HM, Marks AR, Hendrickson WA, Shepard KL. Sub-Microsecond-Scale Dynamics in the Type-1 Ryanodine Receptor Observed with CMOS-Integrated Electrophysiology Biophysical Journal. 112: 134a. DOI: 10.1016/J.Bpj.2016.11.742  0.356
2017 Santulli G, Gambardella J, Reiken S, Yuan Q, Nakashima R, Forrester FM, Lacampagne A, Marks A. Mechanistic Role of Type 1 Inositol 1,4,5-Trisphosphate Receptor in the Regulation of Vascular Tone in Heart Failure Biophysical Journal. 112: 482a. DOI: 10.1016/J.Bpj.2016.11.2610  0.37
2017 Georges Ad, Clarke OB, Zalk R, Yuan Q, Condon KJ, Grassucci RA, Hendrickson WA, Marks AR, Frank J. Functional Study of the Ryanodine Receptor Type 1 using Cryo-Electron Microscopy Biophysical Journal. 112. DOI: 10.1016/J.Bpj.2016.11.1813  0.433
2017 Forrester FM, Umanskaya A, Xie W, Reiken S, Yuan Q, Lacampagne A, Marks A. The Role of Calcium Leak in Age-Dependent Loss of C. Elegans Muscle Function Biophysical Journal. 112: 232a. DOI: 10.1016/J.Bpj.2016.11.1274  0.42
2016 des Georges A, Clarke OB, Zalk R, Yuan Q, Condon KJ, Grassucci RA, Hendrickson WA, Marks AR, Frank J. Structural Basis for Gating and Activation of RyR1. Cell. 167: 145-157.e17. PMID 27662087 DOI: 10.1016/J.Cell.2016.08.075  0.429
2016 Matecki S, Dridi H, Jung B, Saint N, Reiken SR, Scheuermann V, Mrozek S, Santulli G, Umanskaya A, Petrof BJ, Jaber S, Marks AR, Lacampagne A. Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation. Proceedings of the National Academy of Sciences of the United States of America. PMID 27457930 DOI: 10.1073/Pnas.1609707113  0.457
2016 Yuan Q, Yang J, Santulli G, Reiken SR, Wronska A, Kim MM, Osborne BW, Lacampagne A, Yin Y, Marks AR. Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS. Proceedings of the National Academy of Sciences of the United States of America. PMID 27402766 DOI: 10.1073/Pnas.1608859113  0.404
2015 Santulli G, Pagano G, Sardu C, Xie W, Reiken S, D'Ascia SL, Cannone M, Marziliano N, Trimarco B, Guise TA, Lacampagne A, Marks AR. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. The Journal of Clinical Investigation. 125: 4316. PMID 26524594 DOI: 10.1172/Jci84937  0.345
2015 Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, Chiechi A, Wright LE, Umanskaya A, Niewolna M, Trivedi T, Charkhzarrin S, Khatiwada P, Wronska A, Haynes A, ... ... Marks AR, et al. Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nature Medicine. PMID 26457758 DOI: 10.1038/Nm.3961  0.354
2015 Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proceedings of the National Academy of Sciences of the United States of America. PMID 26217001 DOI: 10.1073/Pnas.1513047112  0.349
2015 Santulli G, Marks AR. Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. Current Molecular Pharmacology. 8: 206-22. PMID 25966694 DOI: 10.2174/1874467208666150507105105  0.503
2015 Santulli G, Pagano G, Sardu C, Xie W, Reiken S, D'Ascia SL, Cannone M, Marziliano N, Trimarco B, Guise TA, Lacampagne A, Marks AR. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. The Journal of Clinical Investigation. 125: 1968-78. PMID 25844899 DOI: 10.1172/Jci79273  0.425
2015 Zalk R, Clarke OB, des Georges A, Grassucci RA, Reiken S, Mancia F, Hendrickson WA, Frank J, Marks AR. Structure of a mammalian ryanodine receptor. Nature. 517: 44-9. PMID 25470061 DOI: 10.1038/Nature13950  0.454
2015 Cheung JW, Meli AC, Xie W, Mittal S, Reiken S, Wronska A, Xu L, Steinberg JS, Markowitz SM, Iwai S, Lacampagne A, Lerman BB, Marks AR. Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditions. International Journal of Cardiology. 180: 228-36. PMID 25463374 DOI: 10.1016/J.Ijcard.2014.11.119  0.349
2014 Umanskaya A, Santulli G, Xie W, Andersson DC, Reiken SR, Marks AR. Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging. Proceedings of the National Academy of Sciences of the United States of America. 111: 15250-5. PMID 25288763 DOI: 10.1073/Pnas.1412754111  0.419
2014 Umanskaya A, Andersson D, Xie W, Reiken S, Marks AR. C. Elegans as a Model to Study Ryanodine Receptor Function in Aging Biophysical Journal. 106: 111. DOI: 10.1016/J.Bpj.2013.11.677  0.4
2013 Xie W, Santulli G, Guo X, Gao M, Chen BX, Marks AR. Imaging atrial arrhythmic intracellular calcium in intact heart. Journal of Molecular and Cellular Cardiology. 64: 120-3. PMID 24041536 DOI: 10.1016/J.Yjmcc.2013.09.003  0.408
2013 Subramanyam P, Chang DD, Fang K, Xie W, Marks AR, Colecraft HM. Manipulating L-type calcium channels in cardiomyocytes using split-intein protein transsplicing. Proceedings of the National Academy of Sciences of the United States of America. 110: 15461-6. PMID 24003157 DOI: 10.1073/Pnas.1308161110  0.427
2013 Goldklang MP, Perez-Zoghbi JF, Trischler J, Nkyimbeng T, Zakharov SI, Shiomi T, Zelonina T, Marks AR, D'Armiento JM, Marx SO. Treatment of experimental asthma using a single small molecule with anti-inflammatory and BK channel-activating properties. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 4975-86. PMID 23995289 DOI: 10.1096/Fj.13-235176  0.313
2013 Rullman E, Andersson DC, Melin M, Reiken S, Mancini DM, Marks AR, Lund LH, Gustafsson T. Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 32: 925-9. PMID 23953820 DOI: 10.1016/J.Healun.2013.06.026  0.414
2013 Andersson DC, Betzenhauser MJ, Reiken S, Umanskaya A, Shiomi T, Marks AR. Reply from Daniel C. Andersson, Matthew J. Betzenhauser, Steven Reiken, Alisa Umanskaya, Takayuki Shiomi and Andrew R. Marks. The Journal of Physiology. 591: 3103. PMID 23774683 DOI: 10.1113/Jphysiol.2013.255554  0.328
2013 Marx SO, Marks AR. Dysfunctional ryanodine receptors in the heart: New insights into complex cardiovascular diseases Journal of Molecular and Cellular Cardiology. 58: 225-231. PMID 23507255 DOI: 10.1016/J.Yjmcc.2013.03.005  0.507
2013 Marks AR. Calcium cycling proteins and heart failure: mechanisms and therapeutics. The Journal of Clinical Investigation. 123: 46-52. PMID 23281409 DOI: 10.1172/Jci62834  0.489
2012 Kushnir A, Marks AR. Ryanodine receptor patents. Recent Patents On Biotechnology. 6: 157-66. PMID 23092431 DOI: 10.2174/1872208311206030157  0.468
2012 Andersson DC, Betzenhauser MJ, Reiken S, Umanskaya A, Shiomi T, Marks AR. Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor. The Journal of Physiology. 590: 6381-7. PMID 23070698 DOI: 10.1113/Jphysiol.2012.237925  0.426
2012 Liu X, Betzenhauser MJ, Reiken S, Meli AC, Xie W, Chen BX, Arancio O, Marks AR. Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. Cell. 150: 1055-67. PMID 22939628 DOI: 10.1016/J.Cell.2012.06.052  0.402
2012 Shan J, Xie W, Betzenhauser M, Reiken S, Chen BX, Wronska A, Marks AR. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. Circulation Research. 111: 708-17. PMID 22828895 DOI: 10.1161/Circresaha.112.273342  0.473
2012 Andersson DC, Meli AC, Reiken S, Betzenhauser MJ, Umanskaya A, Shiomi T, D'Armiento J, Marks AR. Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy. Skeletal Muscle. 2: 9. PMID 22640601 DOI: 10.1186/2044-5040-2-9  0.447
2012 Goonasekera SA, Hammer K, Auger-Messier M, Bodi I, Chen X, Zhang H, Reiken S, Elrod JW, Correll RN, York AJ, Sargent MA, Hofmann F, Moosmang S, Marks AR, Houser SR, et al. Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice. The Journal of Clinical Investigation. 122: 280-90. PMID 22133878 DOI: 10.1172/Jci58227  0.428
2012 Sassi Y, Abi-Gerges A, Fauconnier J, Mougenot N, Reiken S, Haghighi K, Kranias EG, Marks AR, Lacampagne A, Engelhardt S, Hatem SN, Lompre AM, Hulot JS. Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 1009-17. PMID 22090316 DOI: 10.1096/Fj.11-194027  0.362
2012 Andersson DC, Betzenhauser MJ, Marks AR. Excitation-contraction coupling in the heart Muscle. 1: 153-159. DOI: 10.1016/B978-0-12-381510-1.00012-0  0.436
2011 Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A, Marks AR. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metabolism. 14: 196-207. PMID 21803290 DOI: 10.1016/J.Cmet.2011.05.014  0.445
2011 Fauconnier J, Meli AC, Thireau J, Roberge S, Shan J, Sassi Y, Reiken SR, Rauzier JM, Marchand A, Chauvier D, Cassan C, Crozier C, Bideaux P, Lompré AM, Jacotot E, ... Marks AR, et al. Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proceedings of the National Academy of Sciences of the United States of America. 108: 13258-63. PMID 21788490 DOI: 10.1073/Pnas.1100286108  0.41
2011 Meli AC, Refaat MM, Dura M, Reiken S, Wronska A, Wojciak J, Carroll J, Scheinman MM, Marks AR. A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium. Circulation Research. 109: 281-90. PMID 21659649 DOI: 10.1161/Circresaha.111.244970  0.372
2011 Betzenhauser MJ, Andersson DC, Reiken S, Marks AR. The Role of Ryanodine Receptor Phosphorylation in Skeletal Muscle Excitation-Contraction Coupling Biophysical Journal. 100: 592a. DOI: 10.1016/J.Bpj.2010.12.3414  0.433
2011 Meli AC, Reiken S, Zalk R, Andersson DC, Betzenhauser MJ, Marks AR. Altered Ca2+ Sensitivity and Gating Properties of Skeletal Muscle Ryanodine Receptors in Aged Mice Biophysical Journal. 100: 417a. DOI: 10.1016/J.Bpj.2010.12.2469  0.465
2011 Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Xie W, Lacampagne A, Marks AR. Preventing Ryanodine Receptor 1 calcium Leak Improves Age-Dependent Muscle Dysfunction Biophysical Journal. 100. DOI: 10.1016/J.Bpj.2010.12.1775  0.436
2010 Andersson DC, Marks AR. Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug Discovery Today. Disease Mechanisms. 7: e151-e157. PMID 21113427 DOI: 10.1016/J.Ddmec.2010.09.009  0.518
2010 Shan J, Kushnir A, Betzenhauser MJ, Reiken S, Li J, Lehnart SE, Lindegger N, Mongillo M, Mohler PJ, Marks AR. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. The Journal of Clinical Investigation. 120: 4388-98. PMID 21099118 DOI: 10.1172/Jci32726  0.505
2010 Shan J, Betzenhauser MJ, Kushnir A, Reiken S, Meli AC, Wronska A, Dura M, Chen BX, Marks AR. Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice. The Journal of Clinical Investigation. 120: 4375-87. PMID 21099115 DOI: 10.1172/Jci37649  0.475
2010 Kushnir A, Marks AR. The ryanodine receptor in cardiac physiology and disease. Advances in Pharmacology (San Diego, Calif.). 59: 1-30. PMID 20933197 DOI: 10.1016/S1054-3589(10)59001-X  0.448
2010 Sampson KJ, Iyer V, Marks AR, Kass RS. A computational model of Purkinje fibre single cell electrophysiology: implications for the long QT syndrome. The Journal of Physiology. 588: 2643-55. PMID 20498233 DOI: 10.1113/Jphysiol.2010.187328  0.39
2010 Kushnir A, Shan J, Betzenhauser MJ, Reiken S, Marks AR. Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proceedings of the National Academy of Sciences of the United States of America. 107: 10274-9. PMID 20479242 DOI: 10.1073/Pnas.1005843107  0.457
2010 Kushnir A, Betzenhauser MJ, Marks AR. Ryanodine receptor studies using genetically engineered mice. Febs Letters. 584: 1956-65. PMID 20214899 DOI: 10.1016/J.Febslet.2010.03.005  0.438
2010 Betzenhauser MJ, Marks AR. Ryanodine receptor channelopathies. PflüGers Archiv : European Journal of Physiology. 460: 467-80. PMID 20179962 DOI: 10.1007/S00424-010-0794-4  0.498
2010 Lompré AM, Hajjar RJ, Harding SE, Kranias EG, Lohse MJ, Marks AR. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation. 121: 822-30. PMID 20124124 DOI: 10.1161/Circulationaha.109.890954  0.445
2010 Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 107: 1559-64. PMID 20080623 DOI: 10.1073/Pnas.0908540107  0.504
2010 Kushnir A, Shan J, Betzenhauser MJ, Reiken S, Marks AR. Reply to Eisner et al.: CaMKII phosphorylation of RyR2 increases cardiac contractility Proceedings of the National Academy of Sciences of the United States of America. 107. DOI: 10.1073/Pnas.1009086107  0.508
2010 Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A. Defective RYR2 Channels Trigger Ventricular Arrhythmias in Duchenne Muscular Dystrophy Biophysical Journal. 98. DOI: 10.1016/J.Bpj.2009.12.1072  0.516
2009 Lindegger N, Hagen BM, Marks AR, Lederer WJ, Kass RS. Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine. Journal of Molecular and Cellular Cardiology. 47: 326-34. PMID 19371746 DOI: 10.1016/J.Yjmcc.2009.04.003  0.428
2009 Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Medicine. 15: 325-30. PMID 19198614 DOI: 10.1038/Nm.1916  0.492
2009 Shan J, Reiken S, Dura M, Meli A, Mongillo M, Marks AR. Role of the Ryanodine Receptor/Calcium Release Channel in Beta-adrenergic Receptor Blocker Treatment of Heart Failure Biophysical Journal. 96. DOI: 10.1016/J.Bpj.2008.12.506  0.446
2009 Meli AC, Zalk R, Wronska A, Karlin A, Marks AR. Mapping the Ryanodine Receptors Pore Region Using the Substituted Cysteine Accessibility Method Biophysical Journal. 96: 106a. DOI: 10.1016/J.Bpj.2008.12.460  0.441
2008 Aydin J, Shabalina IG, Place N, Reiken S, Zhang SJ, Bellinger AM, Nedergaard J, Cannon B, Marks AR, Bruton JD, Westerblad H. Nonshivering thermogenesis protects against defective calcium handling in muscle. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 3919-24. PMID 18687806 DOI: 10.1096/Fj.08-113712  0.407
2008 Lehnart SE, Mongillo M, Bellinger A, Lindegger N, Chen BX, Hsueh W, Reiken S, Wronska A, Drew LJ, Ward CW, Lederer WJ, Kass RS, Morley G, Marks AR. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. The Journal of Clinical Investigation. 118: 2230-45. PMID 18483626 DOI: 10.1172/Jci35346  0.453
2008 Bellinger AM, Reiken S, Dura M, Murphy PW, Deng SX, Landry DW, Nieman D, Lehnart SE, Samaru M, LaCampagne A, Marks AR. Remodeling of ryanodine receptor complex causes "leaky" channels: A molecular mechanism for decreased exercise capacity Proceedings of the National Academy of Sciences of the United States of America. 105: 2198-2202. PMID 18268335 DOI: 10.1073/Pnas.0711074105  0.437
2008 Bellinger AM, Mongillo M, Marks AR. Stressed out: the skeletal muscle ryanodine receptor as a target of stress. The Journal of Clinical Investigation. 118: 445-53. PMID 18246195 DOI: 10.1172/Jci34006  0.447
2007 deSouza N, Cui J, Dura M, McDonald TV, Marks AR. A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation. The Journal of Cell Biology. 179: 923-34. PMID 18056410 DOI: 10.1083/Jcb.200708200  0.442
2007 Lehnart SE, Ackerman MJ, Benson DW, Brugada R, Clancy CE, Donahue JK, George AL, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, ... ... Marks AR, et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation. 116: 2325-45. PMID 17998470 DOI: 10.1161/Circulationaha.107.711689  0.371
2007 Lehnart S, Marks AR. Regulation of ryanodine receptors in the heart. Circulation Research. 101: 746-9. PMID 17932330 DOI: 10.1161/Circresaha.107.162479  0.487
2007 Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, Ackerman MJ. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm. 4: 733-9. PMID 17556193 DOI: 10.1016/J.Hrthm.2007.02.026  0.304
2007 Zalk R, Lehnart SE, Marks AR. Modulation of the ryanodine receptor and intracellular calcium. Annual Review of Biochemistry. 76: 367-85. PMID 17506640 DOI: 10.1146/Annurev.Biochem.76.053105.094237  0.494
2007 Mongillo M, Marks AR. Models of heart failure progression: Ca2+ dysregulation Drug Discovery Today: Disease Models. 4: 191-196. DOI: 10.1016/J.Ddmod.2007.06.005  0.395
2006 Marks AR. Novel therapy for heart failure and exercise-induced ventricular tachycardia based on 'fixing' the leak in ryanodine receptors Novartis Foundation Symposium. 274: 132-147. PMID 17019810 DOI: 10.1002/0470029331.Ch9  0.519
2006 Lehnart SE, Marks AR. Phosphodiesterase 4D and heart failure: a cautionary tale. Expert Opinion On Therapeutic Targets. 10: 677-88. PMID 16981825 DOI: 10.1517/14728222.10.5.677  0.425
2006 Lehnart SE, Terrenoire C, Reiken S, Wehrens XH, Song LS, Tillman EJ, Mancarella S, Coromilas J, Lederer WJ, Kass RS, Marks AR. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proceedings of the National Academy of Sciences of the United States of America. 103: 7906-10. PMID 16672364 DOI: 10.1073/Pnas.0602133103  0.497
2006 Huang F, Shan J, Reiken S, Wehrens XH, Marks AR. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 3456-61. PMID 16481613 DOI: 10.1073/Pnas.0511282103  0.518
2006 Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proceedings of the National Academy of Sciences of the United States of America. 103: 511-8. PMID 16407108 DOI: 10.1073/Pnas.0510113103  0.5
2005 Lehnart SE, Wehrens XH, Reiken S, Warrier S, Belevych AE, Harvey RD, Richter W, Jin SL, Conti M, Marks AR. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell. 123: 25-35. PMID 16213210 DOI: 10.1016/J.Cell.2005.07.030  0.482
2005 Wehrens XH, Lehnart SE, Marks AR. Ryanodine receptor-targeted anti-arrhythmic therapy. Annals of the New York Academy of Sciences. 1047: 366-75. PMID 16093511 DOI: 10.1196/Annals.1341.032  0.504
2005 Lehnart SE, Wehrens XH, Marks AR. Defective ryanodine receptor interdomain interactions may contribute to intracellular Ca2+ leak: a novel therapeutic target in heart failure. Circulation. 111: 3342-6. PMID 15983258 DOI: 10.1161/Circulationaha.105.551861  0.455
2005 Wehrens XH, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proceedings of the National Academy of Sciences of the United States of America. 102: 9607-12. PMID 15972811 DOI: 10.1073/Pnas.0500353102  0.461
2005 Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 111: 2025-32. PMID 15851612 DOI: 10.1161/01.Cir.0000162461.67140.4C  0.463
2005 Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, Marks AR, Burkhoff D. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. Journal of the American College of Cardiology. 45: 668-76. PMID 15734609 DOI: 10.1016/J.Jacc.2004.11.042  0.313
2005 Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annual Review of Physiology. 67: 69-98. PMID 15709953 DOI: 10.1146/Annurev.Physiol.67.040403.114521  0.515
2005 Rodrigue-Way A, Burkhoff D, Geesaman BJ, Golden S, Xu J, Pollman MJ, Donoghue M, Jeyaseelan R, Houser S, Breitbart RE, Marks A, Acton S. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 24: 73-80. PMID 15653383 DOI: 10.1016/J.Healun.2003.10.016  0.352
2005 Lehnart SE, Wehrens XHT, Marks AR. Ryanodine receptors as drug targets for heart failure and cardiac arrhythmias Drug Discovery Today: Therapeutic Strategies. 2: 259-269. DOI: 10.1016/J.Ddstr.2005.08.011  0.505
2005 Marks AR. Enhancing Calstabin Binding to Ryanodine Receptors Improves Both Cardiac and Skeletal Muscle Function in Heart Failure Journal of Cardiac Failure. 11: S231. DOI: 10.1016/J.Cardfail.2005.08.008  0.419
2004 Wehrens XH, Marks AR. Sudden unexplained death caused by cardiac ryanodine receptor (RyR2) mutations. Mayo Clinic Proceedings. 79: 1367-71. PMID 15544013 DOI: 10.4065/79.11.1367  0.385
2004 Lehnart SE, Wehrens XH, Marks AR. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochemical and Biophysical Research Communications. 322: 1267-79. PMID 15336974 DOI: 10.1016/J.Bbrc.2004.08.032  0.529
2004 Wehrens XH, Marks AR. Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nature Reviews. Drug Discovery. 3: 565-73. PMID 15232578 DOI: 10.1038/Nrd1440  0.49
2004 Lehnart SE, Wehrens XH, Kushnir A, Marks AR. Cardiac ryanodine receptor function and regulation in heart disease. Annals of the New York Academy of Sciences. 1015: 144-59. PMID 15201156 DOI: 10.1196/Annals.1302.012  0.511
2004 Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation. 109: 3208-14. PMID 15197150 DOI: 10.1161/01.Cir.0000132472.98675.Ec  0.468
2004 Wehrens XH, Marks AR. Molecular determinants of altered contractility in heart failure. Annals of Medicine. 36: 70-80. PMID 15176427 DOI: 10.1080/17431380410032481  0.468
2004 Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science (New York, N.Y.). 304: 292-6. PMID 15073377 DOI: 10.1126/Science.1094301  0.508
2004 Wehrens XHT, Lehnart SE, Reiken SR, Marks AR. Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor Circulation Research. 94. PMID 15016728 DOI: 10.1161/01.Res.0000125626.33738.E2  0.511
2004 Cui J, Matkovich SJ, deSouza N, Li S, Rosemblit N, Marks AR. Regulation of the type 1 inositol 1,4,5-trisphosphate receptor by phosphorylation at tyrosine 353. The Journal of Biological Chemistry. 279: 16311-6. PMID 14761954 DOI: 10.1074/Jbc.M400206200  0.372
2004 Wehrens XHT, Marks AR. Mechanisms of heart failure: emerging molecular targets Drug Discovery Today: Disease Mechanisms. 1: 9-15. DOI: 10.1016/J.Ddmec.2004.06.001  0.506
2003 Wehrens XHT, Marks AR. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends in Biochemical Sciences. 28: 671-678. PMID 14659699 DOI: 10.1016/J.Tibs.2003.10.003  0.534
2003 Lehnart SE, Huang F, Marx SO, Marks AR. Immunophilins and coupled gating of ryanodine receptors. Current Topics in Medicinal Chemistry. 3: 1383-1391. PMID 12871170 DOI: 10.2174/1568026033451907  0.46
2003 Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D'Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, ... Marks AR, et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 113: 829-40. PMID 12837242 DOI: 10.1016/S0092-8674(03)00434-3  0.493
2003 Ward CW, Reiken S, Marks AR, Marty I, Vassort G, Lacampagne A. Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats The Faseb Journal. 17: 1517-1519. PMID 12824280 DOI: 10.1096/Fj.02-1083Fje  0.433
2003 Reiken S, Wehrens XHT, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR. β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure Circulation. 107: 2459-2466. PMID 12743001 DOI: 10.1161/01.Cir.0000068316.53218.49  0.506
2003 Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy Circulation. 108: 48-53. PMID 12742978 DOI: 10.1161/01.Cir.0000070421.38604.2B  0.305
2003 Marks AR. A Guide for the Perplexed Towards an Understanding of the Molecular Basis of Heart Failure Circulation. 107: 1456-1459. PMID 12654597 DOI: 10.1161/01.Cir.0000059745.95643.83  0.507
2003 Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, Huang F, Gaburjakova M, Gaburjakova J, Rosemblit N, Warren MS, He KL, Yi GH, Wang J, Burkhoff D, ... ... Marks AR, et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. The Journal of Cell Biology. 160: 919-28. PMID 12629052 DOI: 10.1083/Jcb.200211012  0.519
2003 Marks AR. Calcium and the heart: a question of life and death Journal of Clinical Investigation. 111: 597-600. PMID 12618512 DOI: 10.1172/Jci18067  0.436
2003 Marks AR. Arrhythmias of the heart: beyond ion channels. Nature Medicine. 9: 263-264. PMID 12612571 DOI: 10.1038/Nm0303-263  0.438
2003 Kass RS, Kurokawa J, Marx SO, Marks AR. Leucine/isoleucine zipper coordination of ion channel macromolecular signaling complexes in the heart. Roles in inherited arrhythmias. Trends in Cardiovascular Medicine. 13: 52-6. PMID 12586439 DOI: 10.1016/S1050-1738(02)00211-6  0.419
2003 Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, Wang J, Vassort G, Lederer WJ, Marks AR. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. The Journal of Biological Chemistry. 278: 444-53. PMID 12401811 DOI: 10.1074/Jbc.M207028200  0.459
2003 Zhou H, Reiken S, Kherani AR, Warren M, Burkhoff D, Wang J, Marks AR. Effects of beta-blockade treatment on impaired skeletal muscle function and ryanodine receptor/calcium release channel PKA hyperphosphorylation in ischemia-induced heart failure Journal of the American College of Cardiology. 41: 154. DOI: 10.1016/S0735-1097(03)81765-5  0.468
2002 Marx SO, Marks AR. Regulation of the ryanodine receptor in heart failure Basic Research in Cardiology, Supplement. 97. PMID 12479234 DOI: 10.1007/S003950200029  0.551
2002 DeSouza N, Reiken S, Ondrias K, Yang YM, Matkovich S, Marks AR. Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex. The Journal of Biological Chemistry. 277: 39397-400. PMID 12167631 DOI: 10.1074/Jbc.M207059200  0.433
2002 Marks AR. Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death Circulation. 106: 8-10. PMID 12093760 DOI: 10.1161/01.Cir.0000021746.82888.83  0.538
2002 Marks AR, Marx SO, Reiken S. Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers. Trends in Cardiovascular Medicine. 12: 166-170. PMID 12069756 DOI: 10.1016/S1050-1738(02)00156-1  0.514
2002 Semsarian C, Ahmad I, Giewat M, Georgakopoulos D, Schmitt JP, McConnell BK, Reiken S, Mende U, Marks AR, Kass DA, Seidman CE, Seidman JG. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. The Journal of Clinical Investigation. 109: 1013-20. PMID 11956238 DOI: 10.1172/Jci200214677  0.478
2002 Fury M, Marx SO, Marks AR. Molecular BKology: the study of splicing and dicing. Science's Stke : Signal Transduction Knowledge Environment. 2002: pe12. PMID 11891347 DOI: 10.1126/Stke.2002.123.Pe12  0.387
2002 Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. Journal of Cellular Physiology. 190: 1-6. PMID 11807805 DOI: 10.1002/Jcp.10031  0.497
2002 Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, Kass RS. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science (New York, N.Y.). 295: 496-9. PMID 11799244 DOI: 10.1126/Science.1066843  0.417
2002 Marks AR. Ryanodine receptors, FKBP12, and heart failure. Frontiers in Bioscience. 7. DOI: 10.2741/Marks  0.516
2002 Marks AR, Reiken S, Marx SO. Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation. 105: 272-275. DOI: 10.1161/Circ.105.3.272  0.506
2001 Reiken S, Gaburjakova M, Gaburjakova J, He KL, Prieto A, Becker E, Yi GH, Wang J, Burkhoff D, Marks AR. β-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure Circulation. 104: 2843-2848. PMID 11733405 DOI: 10.1161/Hc4701.099578  0.469
2001 Barbone A, Holmes JW, Heerdt PM, The' AH, Naka Y, Joshi N, Daines M, Marks AR, Oz MC, Burkhoff D. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation. 104: 670-5. PMID 11489773 DOI: 10.1161/Hc3101.093903  0.327
2001 Marx SO, Gaburjakova J, Gaburjakova M, Henrikson C, Ondrias K, Marks AR. Coupled gating between cardiac calcium release channels (ryanodine receptors). Circulation Research. 88: 1151-8. PMID 11397781 DOI: 10.1161/Hh1101.091268  0.481
2001 Marx SO, Reiken S, Hisamatsu Y, Gaburjakova M, Gaburjakova J, Yang Y, Rosemblit N, Marks AR. Phosphorylation-Dependent Regulation of Ryanodine Receptors: A Novel Role for Leucine/Isoleucine Zippers Journal of Cell Biology. 153: 699-708. PMID 11352932 DOI: 10.1083/Jcb.153.4.699  0.392
2001 Gaburjakova M, Gaburjakova J, Reiken S, Huang F, Marx SO, Rosemblit N, Marks AR. FKBP12 binding modulates ryanodine receptor channel gating. Journal of Biological Chemistry. 276: 16931-16935. PMID 11279144 DOI: 10.1074/Jbc.M100856200  0.438
2001 Marks AR. Ryanodine receptors/Calcium release channels in heart failure and sudden cardiac death Journal of Molecular and Cellular Cardiology. 33: 615-624. PMID 11273716 DOI: 10.1006/Jmcc.2000.1343  0.545
2000 Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 102: 2713-9. PMID 11094037 DOI: 10.1161/01.Cir.102.22.2713  0.413
2000 Marks AR. Cardiac intracellular calcium release channels: role in heart failure. Circulation Research. 87: 8-11. PMID 10884365 DOI: 10.1161/01.Res.87.1.8  0.548
2000 Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 101: 365-376. PMID 10830164 DOI: 10.1016/S0092-8674(00)80847-8  0.529
2000 Jayaraman T, Marks AR. Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways. Journal of Biological Chemistry. 275: 6417-6420. PMID 10692444 DOI: 10.1074/Jbc.275.9.6417  0.354
1999 Kobrinsky E, Spielman AI, Rosenzweig S, Marks AR. Ceramide triggers intracellular calcium release via the IP(3) receptor in Xenopus laevis oocytes. The American Journal of Physiology. 277: C665-72. PMID 10516096 DOI: 10.1152/Ajpcell.1999.277.4.C665  0.401
1998 Ondrias K, Marx SO, Gaburjakova M, Marks AR. FKBP12 modulates gating of the ryanodine receptor/calcium release channel. Annals of the New York Academy of Sciences. 853: 149-56. PMID 10603943 DOI: 10.1111/J.1749-6632.1998.Tb08263.X  0.437
1998 Marx SO, Ondrias K, Marks AR. Coupled gating between individual skeletal muscle Ca2+ release channels (ryanodine receptors) Science (New York, N.Y.). 281: 818-21. PMID 9694652 DOI: 10.1126/Science.281.5378.818  0.466
1997 Jayaraman T, Marks AR. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Molecular and Cellular Biology. 17: 3005-3012. PMID 9154798 DOI: 10.1128/Mcb.17.6.3005  0.359
1997 Marks AR. Intracellular calcium-release channels: Regulators of cell life and death American Journal of Physiology - Heart and Circulatory Physiology. 272. PMID 9124414 DOI: 10.1152/Ajpheart.1997.272.2.H597  0.502
1996 Marks AR. Expression and regulation of ryanodine receptor/calcium release channels Trends in Cardiovascular Medicine. 6: 130-135. PMID 21232286 DOI: 10.1016/1050-1738(96)00035-7  0.541
1996 Marks AR. Cellular functions of immunophilins Physiological Reviews. 76: 631-649. PMID 8757784 DOI: 10.1152/Physrev.1996.76.3.631  0.408
1996 Kaftan E, Marks AR, Ehrlich BE. Effects of rapamycin on ryanodine receptor/Ca(2+)-release channels from cardiac muscle. Circulation Research. 78: 990-7. PMID 8635249 DOI: 10.1161/01.Res.78.6.990  0.521
1996 Maki T, Gruver EJ, Davidoff AJ, Izzo N, Toupin D, Colucci W, Marks AR, Marsh JD. Regulation of calcium channel expression in neonatal myocytes by catecholamines Journal of Clinical Investigation. 97: 656-663. PMID 8609220 DOI: 10.1172/Jci118462  0.406
1996 Marks AR. Immunophilin modulation of calcium channel gating Methods: a Companion to Methods in Enzymology. 9: 177-187. DOI: 10.1006/Meth.1996.0024  0.44
1995 Kobrinsky E, Ondrias K, Marks AR. Expressed ryanodine receptor can substitute for the inositol 1,4,5-trisphosphate receptor in Xenopus laevis oocytes during progesterone-induced maturation. Developmental Biology. 172: 531-40. PMID 8612969 DOI: 10.1006/Dbio.1995.8058  0.437
1995 Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. The Journal of Clinical Investigation. 95: 888-94. PMID 7860772 DOI: 10.1172/Jci117739  0.496
1995 Harnick DJ, Jayaraman T, Ma Y, Mulieri P, Go LO, Marks AR. The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation. The Journal of Biological Chemistry. 270: 2833-40. PMID 7852357 DOI: 10.1074/Jbc.270.6.2833  0.353
1995 Ma Y, Kobrinsky E, Marks AR. Cloning and expression of a novel truncated calcium channel from non-excitable cells. Journal of Biological Chemistry. 270: 483-493. PMID 7814415 DOI: 10.1074/Jbc.270.1.483  0.421
1995 Jayaraman T, Ondriasová E, Ondrias K, Harnick DJ, Marks AR. The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 92: 6007-11. PMID 7597070 DOI: 10.1073/Pnas.92.13.6007  0.374
1995 Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circulation Research. 76: 412-7. PMID 7532117 DOI: 10.1161/01.Res.76.3.412  0.304
1995 Moschella MC, Watras J, Jayaraman T, Marks AR. Inositol 1,4,5-trisphosphate receptor in skeletal muscle: differential expression in myofibres. Journal of Muscle Research and Cell Motility. 16: 390-400. PMID 7499479 DOI: 10.1007/Bf00114504  0.361
1995 Go LO, Harnick DJ, Marx SO, Fyfe BS, Marks AR, Watras J. 770-5 Chamber Specific Regulation of the Sarcoplasmic Reticulum Calcium ATPase Pump In Human Heart Failure Journal of the American College of Cardiology. 25. DOI: 10.1016/0735-1097(95)92635-I  0.426
1994 Brillantes A-B, Bezprozvannaya S, Marks AR. Developmental and tissue-specific regulation of rabbit skeletal and cardiac muscle calcium channels involved in excitation-contraction coupling. Circulation Research. 75: 503-510. PMID 8062423 DOI: 10.1161/01.Res.75.3.503  0.455
1994 Fitzgerald M, Neylon CB, Marks AR, Woodcock EA. Reduced Ryanodine Receptor Content in Isolated Neonatal Cardiomyocytes Compared with the Intact Tissue Journal of Molecular and Cellular Cardiology. 26: 1261-1265. PMID 7869387 DOI: 10.1006/Jmcc.1994.1145  0.339
1994 Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasová E, Moschella MC, Jayaraman T, Landers M, Ehrlich BE, Marks AR. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 77: 513-23. PMID 7514503 DOI: 10.1016/0092-8674(94)90214-3  0.473
1993 Moschella MC, Marks AR. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. The Journal of Cell Biology. 120: 1137-46. PMID 8382205 DOI: 10.1083/Jcb.120.5.1137  0.515
1992 Takahashi T, Allen PD, Lacro RV, Marks AR, Dennis AR, Schoen FJ, Grossman W, Marsh JD, Izumo S. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. The Journal of Clinical Investigation. 90: 927-35. PMID 1326001 DOI: 10.1172/Jci115969  0.475
1992 Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circulation Research. 71: 18-26. PMID 1318794 DOI: 10.1161/01.Res.71.1.18  0.461
1992 Maki T, Gruver EJ, Toupin D, Marks AR, Marsh JD. Norepinephrine regulates DHP-receptor message in rat cardiac myocytes Journal of Molecular and Cellular Cardiology. 24. DOI: 10.1016/0022-2828(92)92941-5  0.342
1991 Marks AR, Taubman MB, Saito A, Dai Y, Fleischer S. The ryanodine receptor/junctional channel complex is regulated by growth factors in a myogenic cell line. The Journal of Cell Biology. 114: 303-12. PMID 1649198 DOI: 10.1083/Jcb.114.2.303  0.427
Low-probability matches (unlikely to be authored by this person)
2021 Zanou N, Dridi H, Reiken S, Imamura de Lima T, Donnelly C, De Marchi U, Ferrini M, Vidal J, Sittenfeld L, Feige JN, Garcia-Roves PM, Lopez-Mejia IC, Marks AR, Auwerx J, Kayser B, et al. Acute RyR1 Ca leak enhances NADH-linked mitochondrial respiratory capacity. Nature Communications. 12: 7219. PMID 34893614 DOI: 10.1038/s41467-021-27422-1  0.293
2019 R Avula UM, Abrams J, Katchman A, Zakharov S, Mironov S, Bayne J, Roybal D, Gorti A, Yang L, Iyer V, Waase M, Saluja D, Ciaccio EJ, Garan H, Marks AR, et al. Heterogeneity of the action potential duration is required for sustained atrial fibrillation. Jci Insight. 5. PMID 31021331 DOI: 10.1172/Jci.Insight.128765  0.292
1996 Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. The Journal of Clinical Investigation. 98: 2277-83. PMID 8941644 DOI: 10.1172/Jci119038  0.288
2022 Stutzman MJ, Kim CSJ, Tester DJ, Hamrick SK, Dotzler SM, Giudicessi JR, Miotto MC, Gc JB, Frank J, Marks AR, Ackerman MJ. Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential. Stem Cell Reports. PMID 35931078 DOI: 10.1016/j.stemcr.2022.07.002  0.287
2011 Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circulation. Cardiovascular Interventions. 4: 104-11. PMID 21325199 DOI: 10.1161/Circinterventions.110.957332  0.286
2016 Regan J, Waning D, Mohammad K, Mikesell C, Reiken S, Marks A, Guise T. Muscle dysfunction in immune competent mice with osteolytic breast cancer in bone is associated with skeletal muscle oxidation of RyR1 Bone Abstracts. DOI: 10.1530/Boneabs.5.Cabs.Oc4.1  0.284
2023 Liu Y, Reiken S, Dridi H, Yuan Q, Mohammad KS, Trivedi T, Miotto MC, Wedderburn-Pugh K, Sittenfeld L, Kerley Y, Meyer JA, Peters JS, Persohn SC, Bedwell AA, Figueiredo LL, ... ... Marks AR, et al. Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice. Science Translational Medicine. 15: eadf8977. PMID 37756377 DOI: 10.1126/scitranslmed.adf8977  0.284
2009 Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR, Tabas I. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. The Journal of Cell Biology. 186: 783-92. PMID 19752026 DOI: 10.1083/Jcb.200904060  0.284
2009 Williams T, Zalk R, Morton S, Mancia F, Marks AR. Characterization of Conformation-Specific Monoclonal Antibodies Against Skeletal Ryanodine Receptor Biophysical Journal. 96: 1-7. DOI: 10.1016/J.Bpj.2008.12.463  0.284
2012 Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR, Accili D, Tabas I. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metabolism. 15: 739-51. PMID 22503562 DOI: 10.1016/J.Cmet.2012.03.002  0.283
2010 Moss SC, Lightell DJ, Marx SO, Marks AR, Woods TC. Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1. The Journal of Biological Chemistry. 285: 11991-7. PMID 20097763 DOI: 10.1074/Jbc.M109.066621  0.273
2016 Wright LE, Harhash AA, Kozlow WM, Waning DL, Regan JN, She Y, John SK, Murthy S, Niewolna M, Marks AR, Mohammad KS, Guise TA. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo. Oncotarget. PMID 28039445 DOI: 10.18632/Oncotarget.14139  0.271
2023 Sleiman Y, Reiken S, Charrabi A, Jaffré F, Sittenfeld LR, Pasquié JL, Colombani S, Lerman BB, Chen S, Marks AR, Cheung JW, Evans T, Lacampagne A, Meli AC. Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes. Stem Cell Research & Therapy. 14: 266. PMID 37740238 DOI: 10.1186/s13287-023-03502-5  0.27
2002 Marks AR. A mission statement for the JCI at the dawn of the 21st century. Journal of Clinical Investigation. 109: 563-564. PMID 12035810 DOI: 10.1172/Jci15199  0.265
2001 Carmeliet E, Fozzard HA, Hiraoka M, Janse MJ, Ogawa S, Roden DM, Rosen MR, Rudy Y, Schwartz PJ, Matteo PS, Camm JA, Antzelevitch C, Boyden PA, Catterall WA, Fishman GI, ... ... Marks AR, et al. New approaches to antiarrhythmic therapy: Emerging therapeutic applications of the cell biology of cardiac arrhythmias Cardiovascular Research. 52: 345-360. PMID 11738052 DOI: 10.1016/S0008-6363(01)00465-5  0.264
2019 Shekar S, Chien CC, Hartel A, Ong P, Clarke OB, Marks A, Drndic M, Shepard KL. Wavelet denoising of high-bandwidth nanopore and ion channel signals. Nano Letters. PMID 30601669 DOI: 10.1021/Acs.Nanolett.8B04388  0.264
2018 Ong P, Hartel AJ, Schröder I, Giese MH, Shekar S, Clarke O, Marks A, Hendrickson W, Shepard KL. CMOS-Integrated Electrophysiology and Data Analysis by Extended BETA Distributions Reveal Nanosecond Closed State Flickering of the TYPE-1 Ryanodine Receptor Biophysical Journal. 114: 129a. DOI: 10.1016/J.Bpj.2017.11.732  0.263
2008 Oyama MA, Reiken S, Lehnart SE, Chittur SV, Meurs KM, Stern J, Marks AR. Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs is associated with calstabin2 deficiency. Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology. 10: 1-10. PMID 18515204 DOI: 10.1016/J.Jvc.2008.04.003  0.263
2003 Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nature Cell Biology. 5: 781-92. PMID 12907943 DOI: 10.1038/Ncb1035  0.261
2001 Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. Circulation. 103: 2967-72. PMID 11413088 DOI: 10.1161/01.Cir.103.24.2967  0.26
1999 Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 99: 2164-70. PMID 10217658 DOI: 10.1161/01.Cir.99.16.2164  0.258
2001 Marx SO, Marks AR. Bench to bedside: The development of rapamycin and its application to stent restenosis Circulation. 104: 852-855. PMID 11514367 DOI: 10.1161/01.Cir.104.8.852  0.253
1999 Marx SO, Marks AR. Cell cycle progression and proliferation despite 4BP-1 dephosphorylation Molecular and Cellular Biology. 19: 6041-6047. PMID 10454551 DOI: 10.1128/Mcb.19.9.6041  0.249
2012 Totary-Jain H, Sanoudou D, Dautriche CN, Schneller H, Zambrana L, Marks AR. Rapamycin resistance is linked to defective regulation of Skp2. Cancer Research. 72: 1836-43. PMID 22311674 DOI: 10.1158/0008-5472.Can-11-2195  0.249
2016 Wright L, Harhash A, Waning D, Mohammad K, Marks A, Guise T. Bisphosphonates prevent osteolysis and muscle weakness in aromatase inhibitor-treated mice with breast cancer bone metastases Bone Abstracts. DOI: 10.1530/Boneabs.5.Cabs.Oc4.2  0.246
2005 Marks AR. Doctors from hell: the horrific account of Nazi experiments on humans Journal of Clinical Investigation. 116: 2-2. DOI: 10.1172/Jci27539  0.242
2008 Shan J, Nguyen TB, Totary-Jain H, Dansky H, Marx SO, Marks AR. Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 105: 19006-11. PMID 19020099 DOI: 10.1073/Pnas.0809743105  0.24
2002 Marks AR, Reiken S, Marx SO. Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation. 105: 272-5. PMID 11804976  0.24
2002 Marks AR. Ryanodine receptors, FKBP12, and heart failure Frontiers in Bioscience : a Journal and Virtual Library. 7. PMID 11897558  0.239
2004 Dilly KW, Kurokawa J, Terrenoire C, Reiken S, Lederer WJ, Marks AR, Kass RS. Overexpression of beta2-adrenergic receptors cAMP-dependent protein kinase phosphorylates and modulates slow delayed rectifier potassium channels expressed in murine heart: evidence for receptor/channel co-localization. The Journal of Biological Chemistry. 279: 40778-87. PMID 15272004 DOI: 10.1074/Jbc.M406010200  0.235
1985 Moore DD, Marks AR, Buckley DI, Kapler G, Payvar F, Goodman HM. The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America. 82: 699-702. PMID 2983311 DOI: 10.1073/Pnas.82.3.699  0.234
2014 Santulli G, Wronska A, Uryu K, Diacovo TG, Gao M, Marx SO, Kitajewski J, Chilton JM, Akat KM, Tuschl T, Marks AR, Totary-Jain H. A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. The Journal of Clinical Investigation. 124: 4102-14. PMID 25133430 DOI: 10.1172/Jci76069  0.233
2006 Marks AR. In search of memoryThe emergence of a new science of mind Journal of Clinical Investigation. 116: 1131-1131. DOI: 10.1172/Jci28674  0.23
2013 Totary-Jain H, Marks AR. MicroRNAs and the cellular response to rapamycin: potential role in diagnosis and therapy. Cell Cycle (Georgetown, Tex.). 12: 861-2. PMID 23442794 DOI: 10.4161/Cc.24100  0.229
2003 Marks AR. The JCI starts two new series: Science in Medicine and Science and Society Journal of Clinical Investigation. 111: 289. DOI: 10.1172/Jci200317756  0.228
2019 Feng J, Dang Y, Zhang W, Zhao X, Zhang C, Hou Z, Jin Y, McNutt MA, Marks AR, Yin Y. PTEN arginine methylation by PRMT6 suppresses PI3K-AKT signaling and modulates pre-mRNA splicing. Proceedings of the National Academy of Sciences of the United States of America. PMID 30886105 DOI: 10.1073/Pnas.1811028116  0.227
2005 Marks AR. Heart failure and sudden cardiac death: causes and cures. Harvey Lectures. 101: 39-57. PMID 18030974  0.226
2003 Marks AR. DNA: The Secret of Life Journal of Clinical Investigation. 112: 972-972. DOI: 10.1172/Jci200320020  0.224
2008 Marks AR. Physiological systems under pressure. The Journal of Clinical Investigation. 118: 411-2. PMID 18246190 DOI: 10.1172/Jci34756  0.223
2004 Insel PA, Kornfeld S, Majerus PW, Marks AR, Marks PA, Relman AS, Scharschmidt BF, Stossel TP, Varki AP, Weiss SJ, Wilson JD. Blasts from the past. The Journal of Clinical Investigation. 114: 1017-33. PMID 15489944 DOI: 10.1172/Jci23321  0.219
2013 Totary-Jain H, Sanoudou D, Ben-Dov IZ, Dautriche CN, Guarnieri P, Marx SO, Tuschl T, Marks AR. Reprogramming of the microRNA transcriptome mediates resistance to rapamycin. The Journal of Biological Chemistry. 288: 6034-44. PMID 23300087 DOI: 10.1074/Jbc.M112.416446  0.217
2006 Marks AR. Rescuing the NIH: The response Journal of Clinical Investigation. 116: 1460-1461. PMID 16648876 DOI: 10.1172/Jci28893  0.214
2006 Marks AR. Supporting junior faculty in the academic system: Time for a change? Journal of Clinical Investigation. 116: 2310. PMID 16955129 DOI: 10.1172/Jci30001  0.214
2006 Marks AR. Rescuing the NIH before it is too late Journal of Clinical Investigation. 116: 844. PMID 16585950 DOI: 10.1172/Jci28364  0.213
2011 Marks AR. Repaving the road to biomedical innovation through academia. Science Translational Medicine. 3: 89cm15. PMID 21715676 DOI: 10.1126/Scitranslmed.3002223  0.211
2004 Marks AR. Lost gold: the decline of the academic mission in US medical schools. The Journal of Clinical Investigation. 114: 1180. PMID 15520844 DOI: 10.1172/Jci23408  0.209
2004 Marks AR. The economy of science. The Journal of Clinical Investigation. 114: 871. PMID 15467820 DOI: 10.1172/Jci23182  0.208
2005 Marks AR. Desperately seeking diversity Journal of Clinical Investigation. 115: 480. PMID 15765124 DOI: 10.1172/Jci24541  0.207
2007 Marks AR. Physician-scientist, heal thyself. Journal of Clinical Investigation. 117: 2. PMID 17200700 DOI: 10.1172/Jci31031  0.206
2004 Woods TC, Marks AR. Drug-eluting stents. Annual Review of Medicine. 55: 169-178. PMID 14746515 DOI: 10.1146/Annurev.Med.55.091902.105243  0.206
2022 Miotto MC, Marks AR. Catching the next wave of recombinant RyR2 cryo-EM structures. Commentary on "Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations". Cell Calcium. 105: 102614. PMID 35780681 DOI: 10.1016/j.ceca.2022.102614  0.203
2024 Beqaj H, Sittenfeld L, Chang A, Miotto M, Dridi H, Willson G, Jorge CM, Li JA, Reiken S, Liu Y, Dai Z, Marks AR. Location of ryanodine receptor type 2 mutation predicts age of onset of sudden death in catecholaminergic polymorphic ventricular tachycardia - A systematic review and meta-analysis of case-based literature. Medrxiv : the Preprint Server For Health Sciences. PMID 38559077 DOI: 10.1101/2024.03.15.24304349  0.203
2003 Marks AR. Sirolimus for the prevention of in-stent restenosis in a coronary artery. The New England Journal of Medicine. 349: 1307-1309. PMID 14523135 DOI: 10.1056/Nejmp038141  0.202
2009 Marks AR. Health care reform: the differential diagnosis. The Journal of Clinical Investigation. 119: 2853. PMID 20069710 DOI: 10.1172/Jci41022  0.2
2005 Marks AR. How to support the basic sciences. The Journal of Clinical Investigation. 115: 2. PMID 15630432 DOI: 10.1172/Jci23909  0.198
2015 Xie W, Santulli G, Reiken SR, Yuan Q, Osborne BW, Chen BX, Marks AR. Mitochondrial oxidative stress promotes atrial fibrillation. Scientific Reports. 5: 11427. PMID 26169582 DOI: 10.1038/Srep11427  0.198
2003 Marks AR. Book Review Principles and Practice of Clinical Research Edited by John I. Gallin. 490 pp., illustrated. San Diego, Calif., Academic Press, 2002. $99.95. 0-12-274065-3 The New England Journal of Medicine. 348: 1506-1507. DOI: 10.1056/Nejm200304103481523  0.198
2016 Marks AR. The Fukushima nuclear disaster is ongoing. The Journal of Clinical Investigation. 126: 2385-7. PMID 27214552 DOI: 10.1172/Jci88434  0.196
2005 Marks AR. Sex and the university system Journal of Clinical Investigation. 115: 790. PMID 15841161 DOI: 10.1172/Jci24841  0.193
1996 Gallo R, Padurean A, Chesebro JH, Fallon JT, Fuster V, Marks AR, Badimon JJ. Rapamycin (sirolimus) reduces luminal narrowing after balloon angioplasty in porcine coronary arteries Journal of the American College of Cardiology. 27: 198. DOI: 10.1016/S0735-1097(96)81649-4  0.191
2020 Sleiman Y, Souidi M, Kumar R, Yang E, Jaffré F, Zhou T, Bernardin A, Reiken S, Cazorla O, Kajava AV, Moreau A, Pasquié JL, Marks AR, Lerman BB, Chen S, et al. Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes. Ebiomedicine. 60: 103024. PMID 32980690 DOI: 10.1016/j.ebiom.2020.103024  0.191
2006 Neill US, Marks AR. Why we think it is important to discuss intelligent design. The Journal of Clinical Investigation. 116: 1133. PMID 16670752 DOI: 10.1172/Jci28483  0.187
2021 Avula UMR, Dridi H, Chen BX, Yuan Q, Katchman AN, Reiken SR, Desai AD, Parsons S, Baksh H, Ma E, Dasrat P, Ji R, Lin Y, Sison C, Lederer WJ, ... ... Marks AR, et al. Attenuating persistent sodium current induced artial myopathy and fibrillation by preventing mitochondrial oxidative stress. Jci Insight. PMID 34710060 DOI: 10.1172/jci.insight.147371  0.176
2023 Bansia H, Catalano C, Melville Z, Guo Y, Marks AR, des Georges A. Investigating gating mechanisms of ion channels using temperature-resolved cryoEM. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 27: 1690-1694. PMID 37644957 DOI: 10.1017/s1431927621006206  0.17
2008 Seidman CE, Marks AR. A tribute to Ketty Schwartz Journal of Clinical Investigation. 118: 824-824. DOI: 10.1172/Jci35192  0.165
2023 Trivedi T, Manaa M, John S, Reiken S, Murthy S, Pagnotti GM, Dole NS, She Y, Suresh S, Hain BA, Regan J, Ofer R, Wright L, Robling A, Cao X, ... ... Marks AR, et al. Zoledronic acid improves bone quality and muscle function in a high bone turnover state. Biorxiv : the Preprint Server For Biology. PMID 37333318 DOI: 10.1101/2023.06.01.543305  0.162
2023 Dridi H, Yehya M, Barsotti R, Liu Y, Reiken S, Azria L, Yuan Q, Bahlouli L, Soni RK, Marks AR, Lacampagne A, Matecki S. Aberrant mitochondrial dynamics contributes to diaphragmatic weakness induced by mechanical ventilation. Pnas Nexus. 2: pgad336. PMID 37954156 DOI: 10.1093/pnasnexus/pgad336  0.138
2020 Dridi H, Jung B, Yehya M, Daurat A, Reiken S, Moreau J, Marks AR, Matecki S, Lacampagne A, Jaber S. Late Ventilator-Induced Diaphragmatic Dysfunction After Extubation. Critical Care Medicine. PMID 33009102 DOI: 10.1097/CCM.0000000000004569  0.095
2022 Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer's-like signaling in brains of COVID-19 patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35112786 DOI: 10.1002/alz.12558  0.061
2011 Marks A, Maizels M, Mickelson J, Yerkes E, Anthony Herndon CD, Lane J, Ben-Ami T, Maizels E, Stoltz RS, Dixon S, Liu D, Chaviano T, Hagerty J, Kaplan W. Effectiveness of the computer enhanced visual learning method in teaching the society for fetal urology hydronephrosis grading system for urology trainees. Journal of Pediatric Urology. 7: 113-7. PMID 21094626 DOI: 10.1016/j.jpurol.2010.09.009  0.034
2012 Prasad MM, Marks A, Vasquez E, Yerkes EB, Cheng EY. Published surgical success rates in pediatric urology--fact or fiction? The Journal of Urology. 188: 1643-7. PMID 22910257 DOI: 10.1016/j.juro.2012.02.032  0.019
2012 Bauschard M, Maizels M, Kirsch A, Koyle M, Chaviano T, Liu D, Stoltz RS, Maizels E, Prasad M, Marks A, Bolnick D. Computer-Enhanced Visual Learning Method to Teach Endoscopic Correction of Vesicoureteral Reflux: An Invitation to Residency Training Programs to Utilize the CEVL Method. Advances in Urology. 2012: 831384. PMID 22272196 DOI: 10.1155/2012/831384  0.016
2009 Marks A, Vianna DM, Carrive P. Nonshivering thermogenesis without interscapular brown adipose tissue involvement during conditioned fear in the rat. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 296: R1239-47. PMID 19211724 DOI: 10.1152/ajpregu.90723.2008  0.016
2013 Marks A, Vasquez E, Moylan S, Diaz-Saldano D, Schreiber J, Saker M, Lindgren BW. Definition of reliable, objective criteria by abdominal radiography to identify occult constipation in children with lower urinary tract symptoms. The Journal of Urology. 189: 1519-23. PMID 23079375 DOI: 10.1016/j.juro.2012.10.019  0.01
Hide low-probability matches.